Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-30T20:19:05.777Z Has data issue: false hasContentIssue false
  • English
  • Français

Implementation of Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in U.S. Hospitals

Published online by Cambridge University Press:  21 June 2016

Marcia M. Ward ,
Daniel J. Diekema ,
Jon W. Yankey ,
Thomas E. Vaughn ,
Bonnie J. BootsMiller ,
Jane F. Pendergast  and
Bradley N. Doebbeling
Marcia M. Ward*
Affiliation:
Department of Health Management and Policy, University of Iowa, Iowa City, Iowa Center for Research in the Implementation of innovative Strategies in Practice (CRIISP) at the Iowa City Veterans Affairs Medical Center, Iowa City, Iowa
Daniel J. Diekema
Affiliation:
Department of Internal Medicine, University of Iowa, Iowa City, Iowa Center for Research in the Implementation of innovative Strategies in Practice (CRIISP) at the Iowa City Veterans Affairs Medical Center, Iowa City, Iowa Department of Pathology, University of Iowa, Iowa City Veterans Affairs Medical Center, Iowa City, Iowa
Jon W. Yankey
Affiliation:
Center for Research in the Implementation of innovative Strategies in Practice (CRIISP) at the Iowa City Veterans Affairs Medical Center, Iowa City, Iowa
Thomas E. Vaughn
Affiliation:
Department of Health Management and Policy, University of Iowa, Iowa City, Iowa Center for Research in the Implementation of innovative Strategies in Practice (CRIISP) at the Iowa City Veterans Affairs Medical Center, Iowa City, Iowa
Bonnie J. BootsMiller
Affiliation:
Department of Internal Medicine, University of Iowa, Iowa City, Iowa Center for Research in the Implementation of innovative Strategies in Practice (CRIISP) at the Iowa City Veterans Affairs Medical Center, Iowa City, Iowa
Jane F. Pendergast
Affiliation:
Department of Biostatistics, University of Iowa, Iowa City, Iowa
Bradley N. Doebbeling
Affiliation:
Health Services Research and Development, Center on Implementing Evidence-Based Practice, Roudebush Veterans Affairs Medical Center; the Regenstrief Institute, Inc.; and the Department of Internal Medicine, Indiana University Center for Health Services & Outcomes Research, Indiana University School of Medicine, Indianapolis, Indiana
*
Department of Health Management and Policy, College of Public Health, University of Iowa, Iowa City, IA 52242-1008[email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To examine the extent to which the strategies recommended by the National Foundation for Infectious Diseases (NFID)-Centers for Disease Control and Prevention (CDC) co-sponsored workshop, Antimicrobial Resistance in Hospitals: Strategies to Improve Antimicrobial Use and Prevent Nosocomial Transmission of Antimicrobial-Resistant Microorganisms, have been implemented and the relationship between the degree of implementation and hospital culture, leadership, and organizational factors.

Design:

Survey.

Setting:

A representative sample of U.S. hospitals stratified by teaching status, bed size, and geographic region.

Participants:

Infection control professionals.

Results:

Surveyed hospitals had implemented strategies to optimize the use of antimicrobials and to detect, report, and prevent transmission of antimicrobial-resistant microorganisms. Multivariate analyses found that hospitals with a greater degree of implementation of the NFID–CDC strategic goals were more likely to have management support, education of staff, and interdisciplinary groups specifically to address these issues; they were also more likely to engage in benchmarking on broader quality of care indicators.

Conclusions:

Most surveyed hospitals had implemented some measures to address the NFID–CDC recommendations; however, hospitals need to do much more to improve antimicrobial use and to increase their efforts to detect, report, and control the spread of antimicrobial resistance. A supportive hospital administration must foster a culture of ongoing support, education, and interdisciplinary work groups focused on this important issue to successfully accomplish these goals.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 26 , Issue 1 , January 2005 , pp. 21 - 30
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Shlaes, DM, Gerding, DN, John, JF, et al.Society for Healthcare Epidemiology of America and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997;25:584–599.Google Scholar
2.Goldmann, DA, Weinstein, RA, Wenzel, RP, et al.Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA 1996;275:234–240.CrossRefGoogle ScholarPubMed
3.Cohen, ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992;257:1050–1055.Google Scholar
4.Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin: United States, 2002. MMWR 2002;51:565–566.Google Scholar
5.Goldmann, DA, Huskins, WC. Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide. Clin Infect Dis 1997;24(suppl 1):S139–S145.CrossRefGoogle ScholarPubMed
6.Jarvis, WR. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls: the complexity of the problem. Infect Control Hosp Epidemiol 1996;17:490–495.Google Scholar
7.McGowan, JE Jr, Tenover, FC. Control of antimicrobial resistance in the health care system. Infect Dis Clin North Am 1997;11:297–311.Google Scholar
8.Gaynes, R. The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect Dis Clin North Am 1997;11:757–765.CrossRefGoogle ScholarPubMed
9.Shay, DK, Goldmann, DA, Jarvis, WR. Reducing the spread of antimicrobial-resistant microorganisms. Pediatr Clin North Am 1995;42:703–716.CrossRefGoogle ScholarPubMed
10.Boyce, JM. Vancomycin-resistant enterococcus: detection, epidemiology, and control measures. Infect Dis Clin North Am 1997;11:367–384.Google Scholar
11.Casewell, MW. New threats to the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 1995;30(suppl):465–471.CrossRefGoogle Scholar
12.The Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 1995;23:878–894.Google Scholar
13.Garner, JS. Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention: guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:53–80.CrossRefGoogle ScholarPubMed
14.Duncan, RA. Controlling use of antimicrobial agents. Infect Control Hosp Epidemiol 1997;18:260–266.Google Scholar
15.Martone, WJ. Spread of vancomycin-resistant enterococcci: why did it happen in the United States? Infect Control Hosp Epidemiol 1998;19:539–545.Google Scholar
16.Diekema, DJ, Pfaller, MA, Jones, RN, et al.Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clin Infect Dis 1999;29:595–607.Google ScholarPubMed
17.Wakefield, DS, Pfaller, M, Massanari, RM, Hammons, GT. Variation in methicillin-resistant Staphylococcus aureus occurrence by geographic location and hospital characteristics. Infect Control 1987;8:151–157.CrossRefGoogle ScholarPubMed
18.Dillman, DA. Mail and Internet Surveys: The Tailored Design Method, ed. 2. New York: John Wiley and Sons; 2000.Google Scholar
19.Beekmann, SE, Vaughn, TE, McCoy, KD, et al.Hospital bloodborne pathogens programs: program characteristics and blood and body fluid exposure rates. Infect Control Hosp Epidemiol 2001;22:73–82.Google Scholar
20.McCoy, KD, Beekmann, SE, Ferguson, KJ, et al.Monitoring adherence to standard precautions. Am J Infect Control 2001;29:24–31.CrossRefGoogle ScholarPubMed
21.Vaughn, TE, Ward, MM, Doebbeling, BN, Uden-Holman, T, Clarke, WT, Woolson, REOrganizational and provider characteristics fostering smoking cessation clinical guideline adherence: an empirical look. Journal of Ambulatory Care Management 2002;25:17–31.Google Scholar
22.Vaughn, TE, McCoy, K, BootsMiller, BJ, et al.Organizational predictors of adherence to ambulatory care screening guidelines. Med Care 2002;40:1172–1185.Google Scholar
23.Harrell, FE Jr. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer-Verlag; 2001.Google Scholar
24.Harrell, FE, Lee, KL, Califf, RM, Pryor, DB, Rosati, RA. Regression modeling strategies for improved prognostic prediction. Stat Med 1984;3:143–152.CrossRefGoogle ScholarPubMed
25.Lawton, RM, Fridkin, SKGaynes, RP, McGowan, JE Jr, Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Hospitals. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Infect Control Hosp Epidemiol 2000;21:256–259.Google Scholar
26.Lundstrom, T, Pugliese, G, Bartley, J, Cox, J, Guither, C. Organizational and environmental factors that affect worker health and safety and patient outcomes. Am J Infect Control 2002;30:93–106.Google Scholar
27.Solberg, LI. Guideline implementation: what the literature doesn't tell ns. Journal of Quality Improvement 2000;26:525–537.Google Scholar
28.Solberg, LI, Brekke, ML, Fazio, CJ, et al.Lessons from experienced guideline implementers: attend to many factors and use multiple strategies. Journal of Quality Improvement 2000;26:171–188.Google Scholar
29.Institute of Medicine. Crossing the Quality Chasm. Washington, DC: National Academy Press; 2004:137–140.Google Scholar
30.Lammers, JC, Cretin, S, Gilman, S, Calingo, E. Total quality management in hospitals. Med Care 1996;34:463–478.Google Scholar
31.Gershon, RRM, Karkashian, CD, Vlahov, D, et al.Compliance with universal precautions in correctional health care facilities. Journal of Occupational and Environmental Medicine 1999;41:181–189.Google Scholar
32.Grosch, JW, Gershon, RRM, Murphy, LR, Dejoy, DM. Safety climate dimensions associated with occupational exposure to blood-borne pathogens in nurses. Am J Ind Med 1999(suppl 1):122–124.Google Scholar
33.Doebbeling, BN, Vaughn, TE, Woolson, RF, et al.Benchmarking Veterans Affairs medical centers in the delivery of preventive health services. Med Care 2002;40:540–554.Google Scholar
34.Drachmen DA Benchmarking patient satisfaction at academic health centers. Journal of Quality Improvement 1996;22:359–367.Google Scholar
35.Weissman, NW, Allison, JJ, Kiefe, CI, et al.Achievable benchmarks of care: the ABCs of benchmarking. J Eval Clin Pract 1999;5:269–281.Google Scholar
36.O'Neal, PV, Oxean, YA, Ma, Y. Benchmarking mechanical ventilation services in teaching hospitals. J Med Syst 2002;26:227–240.Google Scholar
37.Ellis, J. Sharing the evidence: clinical practice benchmarking to improve continuously the quality of care. J Adv Nursing 2000;32:215–225.CrossRefGoogle ScholarPubMed
38.Grabert, M, Schweiggert, F, Holl, RW. A framework for diabetes documentation and quality management in German: 10 years of experience with DPV. Comput Methods Programs Biomed 2002;69:115–121.Google Scholar
39.Nora, JJ, Diekema, DJ, Vaughn, TE, et al.Antimicrobial resistance (AMR) in epidemiologically-important organisms in U.S. hospitals. Presented at the 39th Annual Meeting of the Infectious Diseases Society of America; October 25-28, 2001; San Francisco, CA.Google Scholar